These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. AbuRahma AF; Robinson PA; Holt SM Surgery; 1999 Oct; 126(4):594-601; discussion 601-2. PubMed ID: 10520903 [TBL] [Abstract][Full Text] [Related]
12. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass. Rychlik IJ; Davey P; Murphy J; O'Donnell ME J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288 [TBL] [Abstract][Full Text] [Related]
13. Broad variation in prosthetic conduit use for femoral-popliteal bypass is not justified on the basis of contemporary outcomes favoring autologous great saphenous vein. Humbarger O; Siracuse JJ; Rybin D; Stone DH; Goodney PP; Schermerhorn ML; Farber A; Jones DW; J Vasc Surg; 2019 Nov; 70(5):1514-1523.e2. PubMed ID: 31147137 [TBL] [Abstract][Full Text] [Related]
14. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments. Kram HB; Gupta SK; Veith FJ; Wengerter KR; Panetta TF; Nwosisi C J Vasc Surg; 1991 Sep; 14(3):386-90. PubMed ID: 1880847 [TBL] [Abstract][Full Text] [Related]
15. Preferential use of vein for above-knee femoropopliteal grafts. Wilson YG; Wyatt MG; Currie IC; Baird RN; Lamont PM Eur J Vasc Endovasc Surg; 1995 Aug; 10(2):220-5. PubMed ID: 7655976 [TBL] [Abstract][Full Text] [Related]
16. Mid- and long-term results of the treatment of infrainguinal arterial occlusive disease with precuffed expanded polytetrafluoroethylene grafts compared with vein grafts. Loh SA; Howell BS; Rockman CB; Cayne NS; Adelman MA; Gulkarov I; Veith FJ; Maldonado TS Ann Vasc Surg; 2013 Feb; 27(2):208-17. PubMed ID: 22998787 [TBL] [Abstract][Full Text] [Related]
17. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. Devine C; McCollum C; J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906 [TBL] [Abstract][Full Text] [Related]
18. Value and limitations of secondary femoropopliteal bypasses with polytetrafluoroethylene. Yang PM; Wengerter KR; Veith FJ; Panetta TF; Nwosisi C; Gupta SK J Vasc Surg; 1991 Sep; 14(3):292-8. PubMed ID: 1880836 [TBL] [Abstract][Full Text] [Related]
19. Fate of the limb after failed femoropopliteal reconstruction. Wooster DL; Provan JL Can J Surg; 1982 Jul; 25(4):393-7. PubMed ID: 7093838 [TBL] [Abstract][Full Text] [Related]
20. Graft type for femoro-popliteal bypass surgery. Twine CP; McLain AD Cochrane Database Syst Rev; 2010 May; (5):CD001487. PubMed ID: 20464717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]